🔬 Public Health Update: Infant Malaria Drug, Autism Subtypes, Brain Age Test and More
From life-saving infant malaria treatments to promising autism therapies and cutting-edge longevity research—this week’s Public Health update covers it all. Discover how science is transforming healthcare one breakthrough at a time.
Here’s what you’ll learn in this episode:
💉 First-ever malaria drug approved for newborns under 4.5 kg
🔬 H. pylori infection could be behind up to 12 million future stomach cancer cases
🧠 Probiotics ease hyperactivity in children with autism and ADHD
🏋️♀️ Personality-matched fitness boosts mental and physical health
🍔 Colon cancer rates are rising sharply in adults under 50
🧬 Five biologically distinct autism subtypes revealed
💊 Antidepressant withdrawal more severe than widely believed
🧪 Brain age predicts longevity—new Stanford test shows up to 182% increase in death risk with aged brains
🧃 Creatine isn’t just for muscles—new methods make it vital for brain health
🧬 Experimental mitochondrial therapy restores energy in child with rare genetic condition
Each update is backed by cutting-edge science, critical statistics, and a clear look at what these findings mean for global health.
Whether you’re a clinician, researcher, policymaker, or just passionate about public health—this video delivers what you need to stay informed.
📢 Stay Ahead in Public Health Research!
✅ Like, share, and subscribe for weekly updates on Public Health
#PublicHealth #MedicalNews #GlobalHealth #AutismResearch #CancerPrevention #MalariaTreatment #BrainHealth #LongevityScience #HealthInnovation #LucidQuest #HealthcareConsulting